Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Fluorine F 18 Flurpiridaz · BMS747158

Radiopharmaceutical · Acts on mitochondrial complex 1 (MC-1) · developed by Lantheus Medical Imaging

Phase 3 Most advanced trial (none active)
LNTH Developer
2 Registered trials

What is Fluorine F 18 Flurpiridaz?

Fluorine F 18 flurpiridaz is a radioconjugate, an analog of the mitochondrial complex 1 inhibitor pyridaben labeled with fluorine F 18, used for PET myocardial perfusion imaging. It binds mitochondrial complex 1 in biologically active mitochondria, which are denser in cardiac muscle, and its extraction is proportional to blood flow, so infarcted tissue shows lower radioactivity. It is studied in healthy subjects and in coronary artery disease.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
BMS747158, Flurpiridaz F18
Drug type
Radiopharmaceutical
Targets
mitochondrial complex 1 (MC-1)
Mechanism
Acts on mitochondrial complex 1 (MC-1)
Pathways
mitochondrial respiration, myocardial perfusion
Therapy area
Cardiovascular
Developer
Lantheus Medical Imaging (LNTH)
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 3

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT01347710 Phase 3 Coronary Artery Disease Completed LNTH
NCT00707499 Phase 1 Healthy Completed LNTH

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Coronary Artery DiseaseHealthy

More from Lantheus Medical Imaging

Sources

Updated Nov 15, 2026. Something wrong or missing? Report it on the LNTH page.

Follow LNTH, the company behind Fluorine F 18 Flurpiridaz

See LNTH's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

LNTH catalysts and pipeline →
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.